Renovis Announces Expiration of Hart-Scott-Rodino (HSR) 30-Day Waiting Period; Merger With Evotec on Track to Close in Early May, 2008

SOUTH SAN FRANCISCO, Calif., April 3, 2008 /PRNewswire-FirstCall/ -- Renovis, Inc. (Nasdaq: RNVS ), a biopharmaceutical company focused on the discovery and development of drugs for major medical needs in the areas of neurological and inflammatory diseases, announced today that the waiting pe...

Evotec Completes Divesture of Chemical Development Business to Aptuit

...ORD, England, December 3 /PRNewswire-FirstCall/ -- evotec AG (Frankfurt Stock Exchange: EVT) today announced...ctive November 30, 2007. This divestiture allows evotec to focus even more on its strategy to become an em...ny. Dr Mario Polywka, Chief Operating Officer of evotec AG, commented: "Evotec has decided to focus on cor...

Evotec to Report Third Quarter Results on 13 November 2007

... HAMBURG, Germany and OXFORD, England, November 8 /PRNewswire-FirstCall/ -- evotec AG (Frankfurt Stock Exchange: EVT) will report its financial results for th...ebsite: http://www.evotec.com - Investors - Financial Reports. Contact: evotec AG Anne Hennecke SVP, Investor Relations & Corporate Communications Phon...

Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness

...ORD, England, October 16 /PRNewswire-FirstCall/ -- evotec AG (Frankfurt Stock Exchange: EVT) announced today...r John Kemp, Chief Research & Development Officer, evotec AG. "Due to its partial positive allosteric modula...Jorn Aldag, President and Chief Executive Officer, evotec AG, said: "The positive outcome of this second cli...

Renovis Announces Management Changes

... member until such time as the Company merges with evotec AG (XETRA:EVT.DE), the Hamburg, Germany-based CNS ...n exhibit the Agreement and Plan of Merger between evotec and Renovis. evotec intends to file a Registration Statement on Form F...

Alzheimer’s disease trial With EVT 101 For Successfully Complete

... Alzheimer’s disease is a dreaded disease for the elderly. In the direction of its treatment , the effort of evotec AG (Frankfurt Stock Exchange: EVT, TecDAX 30, "Evotec") has successfully completed the single ascending dose component // of the Phase I clinical stud...

Evotec in Medical Technology

Ono Enters into a New Fragment-Based Drug Discovery Agreement with Evotec

Up to Three-Year Integrated Drug Discovery Support Program HAMBURG, Germany and OXFORD, England, March 27 /PRNewswire-FirstCall/ -- Evotec AG (Frankfurt Stock Exchange: EVT) announced today that the Company and Ono Pharmaceutical Co., Ltd. (Osaka, Japan) signed a new drug discovery agre...

Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line Results with ...

- Both co-primary endpoints, Wake After Sleep Onset and Total Sleep Time, and key secondary endpoints, including Latency to Persistent Sleep, were met at both doses - Evotec to host a conference call at 4pm CET (3pm UK time, 10am EST) today HAMBURG, Germany | OXFORD, England, June 4, 2007-- Evot...

Evotec's EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity During the Performance of Cognitive Tasks

...XFORD, England, March 28 /PRNewswire-FirstCall/ -- evotec (Frankfurt Stock Exchange: EVT) is pleased to anno...redicted to be clinically relevant. In addition, evotec has satisfactorily completed dosing of its four we...er, Executive Vice President Clinical Development, evotec AG. Dr Mitul Mehta, academic lead for the projec...

Evotec Reports Positive Proof-of-Concept Top-Line Results with Insomnia Drug Candidate EVT 201

..., England, June 04, 2007 /PRNewswire-FirstCall/ -- evotec AG announced today positive top-line results from ...Jorn Aldag, President and Chief Executive Officer, evotec AG, said: "We are very pleased with the positive o...hn Kemp, Chief Research & Development Officer, evotec AG, added: "We have always considered that EVT 201...

Evotec in Biological Technology

Spermatech Selects Evotec as Partner for High-Throughput Screening and Lead Discovery

HAMBURG, Germany and OXFORD, England and OSLO, March 12 /PRNewswire-FirstCall/ -- Evotec AG (Frankfurt Stock Exchange: EVT) announced today that Spermatech A/S has chosen them as a partner to identify small molecule therapeutics for their pharmaceutical discovery project. Through the study o...

Renovis Stockholders Approve Acquisition by Evotec

SOUTH SAN FRANCISCO, Calif., May 1 /PRNewswire-FirstCall/ -- Renovis, Inc. (Nasdaq: RNVS ) announced today that its stockholders approved the adoption of the merger agreement with Evotec AG (Frankfurt Stock Exchange: EVT) at a special meeting of stockholders held today. The merger is expected...

Proxy Governance and Egan-Jones Recommend Renovis Shareholders Vote For Merger With Evotec

SOUTH SAN FRANCISCO, Calif., April 25 /PRNewswire-FirstCall/ -- Renovis, Inc. (Nasdaq: RNVS ), today announced that PROXY Governance, Inc. and Egan-Jones Proxy Services have joined ISS/Risk Metrics and Glass Lewis & Co. in recommending that Renovis stockholders vote "FOR" the merger agreement...

Glass Lewis & Co. Recommends Renovis Shareholders Vote For Merger With Evotec

SOUTH SAN FRANCISCO, April 22 /PRNewswire-FirstCall/ -- Renovis, Inc. (Nasdaq: RNVS ), today announced that Glass Lewis & Co., a leading proxy advisory firm, has joined ISS/Risk Metrics in recommending that Renovis stockholders vote "FOR" the merger agreement with Evotec AG (Frankfurt Stock E...

Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value

...ause most recent mergers involving companies similarly situated to Avigen (e.g., Transcept Pharmaceuticals, Inc., Anesiva, Inc., ARCA biopharma, Inc., evotec Aktiengesellschaft, Cardiovascular Systems, Inc. and others), managed to destroy stockholder value. In each of these transactions, the stock prices d...

Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New Report by Global Industry Analysts

... Group, Caliper Life Sciences, Capital GenomiX, Caprion Proteomics, Charles River Laboratories International, ChemBridge Corporation, deCODE Genetics, evotec AG, Galapagos NV, Incyte Corporation, Infinity Pharmaceuticals Inc, Invitrogen Corporation, Medarex, Merck & Co., Millennium Pharmaceuticals, Nati...

Evotec Announces Financial Results for 2007

...XFORD, England, March 28 /PRNewswire-FirstCall/ -- evotec AG (Frankfurt Stock Exchange: EVT) today reported ...nsactions, the acquisition of Neuro3d, the sale of evotec Technologies (ET), the sale of the Chemical Develo...rough the acquisition of Neuro3D, S.A. received - evotec Technologies sold to PerkinElmer for EUR 23.9m - ...

Evotec's Registration Statement in Connection With its Proposed Acquisition of Renovis Declared Effective

...XFORD, England, March 26 /PRNewswire-FirstCall/ -- evotec AG (Frankfurt Stock Exchange, Prime Standard, ISIN...t purpose. The board of directors of Renovis and evotec have approved the transaction and the board of dir...iming of the completion of the transaction between evotec and Renovis, the anticipated benefits of the busin...

Evotec AG: Fiscal Year 2007 Results Presentation on March 28, 2008 Live on the Internet

... HAMBURG, Germany and OXFORD, England, March 20 /PRNewswire-FirstCall/ -- evotec AG (Frankfurt Stock Exchange: EVT) is going to broadcast its annual analyst... our website: http://www.evotec.com - Investors - Webcasts. Contact: evotec AG Anne Hennecke SVP, Investor Relations & Corporate Communications Phon...

Renovis Reports Fourth Quarter and Full Year 2007 Financial Results

...curred in connection with our proposed merger with evotec AG. The majority of these advisory costs will be p...n exhibit the Agreement and Plan of Merger between evotec and Renovis. On January 7, 2008, evotec filed a Registration Statement on Form F-4 with th...